Scio-323, CAS 309913-51-7

Product Description: Scio-323 is an orally available p38 mitogen-activated protein kinase (MAPK) inhibitor with the potential to inhibit chronic inflammatory responses associated with polyethylene particles. Scio-323's oral inhibition pattern had a minimal effect on bone formation. Scio-323 administration inhibited net bone formation after the establishment of a chronic inflammatory response to polyethylene particles. Osteoblast-like activity remained low in all cases of Scio-323 inhibition. Scio-323 failed to improve bone growth in the presence of polyethylene particles[1].

Applications: COVID-19-immunoregulation

Formula: C27H30FN3O4

References: [1]Efficacy of a p38 mitogen activated protein kinase inhibitor in mitigating an established inflammatory reaction to polyethylene particles in vivo

CAS Number: 309913-51-7

Molecular Weight: 479.54

Research Area: Inflammation/Immunology

Target: Endogenous Metabolite

• Artikelnummer: MEXHY-167679-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-167679-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK